Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Safety, Tolerability and Preliminary Efficacy of DRM01B Topical Gel in Healthy Volunteers and Subjects With Acne Vulgaris

NCT01936324 is registered in ClinicalTrials.gov with Dermira, Inc. as lead sponsor.

NCT NCT01936324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01936324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Safety, Tolerability and Preliminary Efficacy of DRM01B Topical Gel in Healthy Volunteers and Subjects With Acne Vulgaris
Lead sponsor
Dermira, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2013
Completion date
June 30, 2014
Enrollment
114 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris